WHO ICTRP trial

Hormone treatment of boys with absent or delayed puberty

EUCTR2012-002337-11-SE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2012-002337-11-SE
Public title Hormone treatment of boys with absent or delayed puberty
Scientific title A multicenter and randomised clinical study on pubertal replacement therapy in boys - Treatment of boys with absent or delayed puberty with rhFSH and two different formulations of testosterone in low dose: Testoviron Depot® and Nebido® - Pubertal replacement therapy in boys
Primary sponsor Västra Götalandsregionen (VGR)
Secondary sponsors Sahlgrenska Academy-Gothenburg University Institute
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries Sweden
Conditions Delayed or absence of puberty MedDRA version: 15.1 Level: LLT Classification code 10012180 Term: Delay in sexual development and puberty, not elsewhere classified System Organ Class: 100000004860 ;Therapeutic area: Body processes [G]…
Interventions Trade Name: Testoviron Depot® Soulution for injection i.m. 250mg/mL Pharmaceutical Form: Solution for injection INN or Proposed INN: TESTOSTERONE Concentration unit: mg milligram(s) Concentration type: range Concentration number: 50-75…
Registration date Jun 18, 2012
Target size 70
Secondary IDs Pub-01
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations